← All diseases
Cancer
Lung cancer (non-small cell)
Do you want to receive a message when there is new research on Lung cancer (non-small cell)? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, one sentence appears above each publication explaining what was studied — and you'll be notified as soon as new research about Lung cancer (non-small cell) is available. View what Premium costs.
Publications and studies (3237)
- Role of prognostic nutritional index in postoperative radiotherapy for non-small cell lung cancer. (2023/10/01) ♡
- Elevated serum lactate dehydrogenase to albumin ratio is a useful poor prognostic predictor of nivolumab in patients with non-small cell lung cancer. (2023/10/01) ♡
- Highlights in non-small cell lung cancer from the IASLC 2023 World Conference on Lung Cancer. (2023/10/01) ♡
- Highlights in non-small cell lung cancer from the IASLC 2023 World Conference on Lung Cancer: commentary. (2023/10/01) ♡
- Role of curcumin in miR-26a and its effect on DNMT1, DNMT3b, and MEG3 expression in A549 lung cancer cell. (2023/10/01) ♡
- Predictors of response in EGFR mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors (2023/10/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A novel EML4-NTRK3 fusion in lung adenocarcinoma with dramatic response to entrectinib. (2023/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Traditional Chinese medicines for non-small cell lung cancer: Therapies and mechanisms. (2023/09/21) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Impact of PD-1/PD-L1 inhibitors on survival in stage III non-small-cell lung cancer: A systematic review. (2023/09/21) ♡
- Combined early palliative care for non-small-cell lung cancer patients: a randomized controlled trial in Chongqing, China. (2023/09/14) ♡
- Polygenic risk score for ulcerative colitis predicts immune checkpoint inhibitor-mediated colitis. (2023/09/13) ♡
- The Prognostic Value of the Novel Global Immune-Nutrition-Inflammation Index (GINI) in Stage IIIC Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemoradiotherapy. (2023/09/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Successful treatment of immune-related lichenoid dermatitis by Weiling decoction in a patient with non-small cell lung cancer: A case report and review of literature. (2023/09/01) ♡
- Scoparone induces both apoptosis and ferroptosis via multiple mechanisms in non-small-cell lung cancer cells. (2023/09/01) ♡
- Ethanol Extract of Citrus grandis' Tomentosa 'Exercises Anticancer Effects by Targeting SKP2/p27 Pathway in Non-Small Cell Lung Cancer. (2023/09/01) ♡
- Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer. (2023/09/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Anamorelin in Japanese patients with cancer cachexia: an update. (2023/09/01) ♡
- Methylseleninic acid overcomes gefitinib resistance through asparagine-with-TOPK signaling axis in non-small cell lung cancer cells. (2023/09/01) ♡
- Correlations between class I glucose transporter expression patterns and clinical outcomes in non-small cell lung cancer. (2023/09/01) ♡
- Early-stage study (phase 1 or 2)iEarly research in a small group, primarily aimed at safety and dosage. Whether it actually works still needs to be determined afterward. Pembrolizumab as first-line treatment for advanced NSCLC in older adults: A phase II clinical trial evaluating geriatric and quality-of-life outcomes. (2023/09/01) ♡
- Predictive Value of Modified Glasgow Prognostic Score and Persistent Inflammation among Patients with Non-Small Cell Lung Cancer Treated with Durvalumab Consolidation after Chemoradiotherapy: A Multicenter Retrospective Study. (2023/09/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Naples prognostic score as a predictor of outcomes in lung cancer: a systematic review and meta-analysis. (2023/09/01) ♡
- Risk factors influencing chemotherapy compliance and survival of elderly patients with non-small cell lung cancer. (2023/09/01) ♡
- Incidence and predictors of infections in patients with advanced non-small cell lung cancer treated with checkpoint inhibitor immunotherapies: A monocentric retrospective cohort study. (2023/09/01) ♡
- Obesity and risk for respiratory diseases: a Mendelian randomization study. (2023/08/29) ♡
- The value of CRP-albumin-lymphocyte index (CALLY index) as a prognostic biomarker in patients with non-small cell lung cancer. (2023/08/23) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Physical exercise reverses immuno-cold tumor microenvironment via inhibiting SQLE in non-small cell lung cancer. (2023/08/18) ♡
- A novel quinoline derivative, DFIQ, sensitizes NSCLC cells to ferroptosis by promoting oxidative stress accompanied by autophagic dysfunction and mitochondrial damage. (2023/08/16) ♡
- DNMT3A governs tyrosine kinase inhibitors responses through IAPs and in a cell senescence-dependent manner in non-small cell lung cancer. (2023/08/15) ♡
- The D-trace loss cluster for differential network analysis. (2023/08/14) ♡
- Role of ALK Inhibitors in Anaplastic Large Cell Lymphoma Experience from an Indian Center. (2023/08/12) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. The role of proteasomes in tumorigenesis. (2023/08/06) ♡
- Design, synthesis, and biological activity of dual monoamine oxidase A and heat shock protein 90 inhibitors, N-methylpropargylamine-conjugated 4-isopropylresorcinol for glioblastoma (2023/08/05) ♡
- JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China. (2023/08/04) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. A meta-analysis of the Zilongjin tablets for non-small cell lung cancer and its network pharmacology of action against NSCLC and COVID-19. (2023/08/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. [Prediction and analysis of Q-markers of Elephantopus scaber based on its UPLC fingerprint, content determination of components, and in vitro an anti-tumor activity]. (2023/08/01) ♡
- Analysis of Serious Weight Gain in Patients Using Alectinib for ALK-positive Lung Cancer. (2023/08/01) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Adenosine monophosphate-activated protein kinase is elevated in human cachectic muscle and prevents cancer-induced metabolic dysfunction in mice. (2023/08/01) ♡
- Is the Preoperative Prognostic Nutritional Index a Useful Marker for the Decision to Perform Limited Resection in High-risk Patients With Stage I Non-small Cell Lung Cancer? (2023/08/01) ♡
- Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Identification of prognostic nutritional index as a reliable prognostic indicator for advanced lung cancer patients receiving immune checkpoint inhibitors. (2023/07/28) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Molecular testing in non-small cell lung cancer: A consensus recommendation. (2023/07/28) ♡
- [A Prognostic Model of Elderly Patients with Non-small Cell Lung Cancer Based on Geriatric Nutritional Risk Index]. (2023/07/20) ♡
- Multimodal prehabilitation in patients with non-small cell lung cancer undergoing anatomical resection: protocol of a non-randomised feasibility study. (2023/07/19) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Predictive value of the prognostic nutritional index in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis. (2023/07/19) ♡
- Clinical application of common inflammatory and nutritional indicators before treatment in prognosis evaluation of non-small cell lung cancer: a retrospective real-world study. (2023/07/13) ♡
- The development and validation of a nomogram for predicting brain metastases after chemotherapy and radiotherapy in male small cell lung cancer patients with stage III. (2023/07/11) ♡
- Single-cell RNA sequencing reveals enhanced antitumor immunity after combined application of PD-1 inhibitor and Shenmai injection in non-small cell lung cancer. (2023/07/10) ♡
- Prognostic roles of hematological indicators for the efficacy and prognosis of immune checkpoint inhibitors in patients with advanced tumors: a retrospective cohort study. (2023/07/07) ♡
- Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Sacubitril/Valsartan Ameliorates Crizotinib-Induced Cardiotoxicity in Mice. (2023/07/03) ♡
- The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors. (2023/07/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.